Rectal Adenocarcinoma
Showing NaN - NaN of 7
Colon Adenocarcinoma, ERBB2 Gene Amplification, Rectal Adenocarcinoma Trial in Puerto Rico, United States (biological, drug,
Active, not recruiting
- Colon Adenocarcinoma
- +18 more
- Cetuximab
- +5 more
-
Anchorage, Alaska
- +797 more
Jan 9, 2023
Quality of Life and Utilities Following Surgical Treatment of
Recruiting
- Rectal Adenocarcinoma
- +13 more
- Quality-of-Life Assessment
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v7, Stage III Rectal Cancer AJCC v7 Trial in Puerto Rico, United States
Active, not recruiting
- Rectal Adenocarcinoma
- +2 more
- Capecitabine
- +6 more
-
Birmingham, Alabama
- +649 more
Aug 5, 2022
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8 Trial in Houston (drug, other, procedure)
Not yet recruiting
- Rectal Adenocarcinoma
- +8 more
- Chemotherapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Colon Adenocarcinoma
- +10 more
- Anti-PD-L1/TGFbetaRII Fusion Protein M7824
-
Houston, TexasM D Anderson Cancer Center
Jan 12, 2022
Young-Onset Colorectal Cancer
Active, not recruiting
- Colon Adenocarcinoma
- +2 more
- Biospecimen Collection
- +3 more
-
Conroe, Texas
- +4 more
Nov 30, 2021
Fecal Incontinence, Low Anterior Resection Syndrome, Malignant Anal Tumor Trial in Houston, Sugar Land (procedure, other,
Recruiting
- Fecal Incontinence
- +19 more
- Explantation
- +5 more
-
Houston, Texas
- +1 more
Aug 21, 2019